David D. Stenehjem

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

Gary H. Lyman, Marc Carrier, Cihan Ay et al. · Blood Advances · 2021 · 849 citations · Full text

Medicine, Hematology, Oncology +17

Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer

David Waterhouse, Jenny Lam, Keith A. Betts et al. · Lung Cancer · 2021 · 141 citations · Full text

Medicine, Immunology, Oncology +12

Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy

Jason I. Griffiths, Pierre Wallet, Lance Pflieger et al. · Proceedings of the National Academy of Sciences · 2020 · 101 citations · Full text

Medicine, Immunology, Oncology +17

Competitive Inhibition of Organic Anion Transporting Polypeptide 1c1-Mediated Thyroxine Transport by the Fenamate Class of Nonsteroidal Antiinflammatory Drugs

Daniel E. Westholm, David D. Stenehjem, Jon N. Rumbley et al. · Endocrinology · 2008 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma

James A. Kuzman, David D. Stenehjem, Joseph A. Merriman et al. · BMC Urology · 2017 · 48 citations · Full text

Medicine, Hematology, Oncology +17